series-a
Stage
3
Investors
About
PulseMedica is developing a non-invasive platform to screen and treat vitreoretinal diseases, beginning with symptomatic vitreous opacities (eye floaters), using image-guided laser technology.
Explore PulseMedica's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.